SNCA and multiple system atrophy: Indeed, mounting evidence indicates that α-synuclein can also be cleared by the glymphatic system, with the first indication coming from studies on MSA, a rare progressive neurodegenerative disease marked by aggregated α-synuclein in glia [169].